Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +35.77%
#2 Siren Siren +30.76%
#3 Purr Purr +29.34%
#4 OriginTrail OriginTrail +23.32%
#5 UnifAI Network UnifAI Network +16.08%
#6 龙虾 (Lobster) 龙虾 (Lobster) +14.51%
#7 Pendle Pendle +14.37%
#8 ApeX ApeX +14.28%
#9 Morpho Morpho +13.97%
#10 Wrapped XPL Wrapped XPL +13.78%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Classement en actions #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Prix de l'action
$3.01
Dernière synchronisation: 2024-04-12
Capitalisation boursière
$104.64M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Cyteir Therapeutics, Inc. (CYT)

Catégorie

Healthcare
Ratio P/B pour Cyteir Therapeutics, Inc. (CYT)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Cyteir Therapeutics, Inc., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Cyteir Therapeutics, Inc. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH